BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 25277610)

  • 1. Nonpharmacological lipoprotein apheresis reduces arterial inflammation in familial hypercholesterolemia.
    van Wijk DF; Sjouke B; Figueroa A; Emami H; van der Valk FM; MacNabb MH; Hemphill LC; Schulte DM; Koopman MG; Lobatto ME; Verberne HJ; Fayad ZA; Kastelein JJ; Mulder WJ; Hovingh GK; Tawakol A; Stroes ES
    J Am Coll Cardiol; 2014 Oct; 64(14):1418-26. PubMed ID: 25277610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein apheresis.
    Moriarty PM; Hemphill L
    Cardiol Clin; 2015 May; 33(2):197-208. PubMed ID: 25939293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot trial to examine the effect of high-dose niacin on arterial wall inflammation using fluorodeoxyglucose positron emission tomography.
    deGoma EM; Salavati A; Shinohara RT; Saboury B; Pollan L; Schoen M; Torigian DA; Mohler ER; Dunbar RL; Litt HI; Woo J; Rader DJ; Alavi A; Mehta NN
    Acad Radiol; 2015 May; 22(5):600-9. PubMed ID: 25708866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small, dense high-density lipoprotein 3 particles exhibit defective antioxidative and anti-inflammatory function in familial hypercholesterolemia: Partial correction by low-density lipoprotein apheresis.
    Hussein H; Saheb S; Couturier M; Atassi M; Orsoni A; Carrié A; Therond P; Chantepie S; Robillard P; Bruckert E; Chapman MJ; Kontush A
    J Clin Lipidol; 2016; 10(1):124-33. PubMed ID: 26892129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging low-density lipoprotein (LDL) therapies: Management of severely elevated LDL cholesterol--the role of LDL-apheresis.
    McGowan MP
    J Clin Lipidol; 2013; 7(3 Suppl):S21-6. PubMed ID: 23642325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-density lipoprotein apheresis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating progenitor cells in patients with familial hypercholesterolemia.
    Sandesara PB; Ramjee V; Ghasemzadeh N; Guo Y; Bhatia N; Li Q; Vaughn L; Nell-Dybdahl C; Waller EK; Mahar EA; Brigham K; Wilson PWF; Quyyumi A; Le NA; Sperling LS
    J Clin Apher; 2018 Jun; 33(3):404-408. PubMed ID: 29114919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidizability of atherogenic low-density lipoprotein subspecies in severe familial hypercholesterolemia: impact of long-term low-density lipoprotein apheresis.
    Lepage S; Nigon F; Bonnefont-Rousselot D; Assogba U; Goulinet S; Chancharme L; Delattre J; Bruckert E; Chapman MJ
    J Cardiovasc Pharmacol Ther; 2000 Apr; 5(2):87-103. PubMed ID: 11150388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the role of lipoprotein apheresis in the management of familial hypercholesterolemia.
    Lee WP; Datta BN; Ong BB; Rees A; Halcox J
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):363-70. PubMed ID: 22149315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of LDL-receptor expression by LDL-immunoapheresis in patients with familial hypercholesterolemia.
    Streicher J; Valent P; Schmidt H; Sengölge G; Wagner O; Strobl W; Hörl WH; Derfler K
    J Investig Med; 1999 Sep; 47(8):378-87. PubMed ID: 10510590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of low-density lipoprotein apheresis on circulating endothelial progenitor cells in familial hypercholesterolemia.
    Ramunni A; Brescia P; Dambra P; Capuzzimati L; Ria R; De Tullio G; Resta F; Russi G; Vacca A; Coratelli P
    Blood Purif; 2010; 29(4):383-9. PubMed ID: 20484899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive correlation between malondialdehyde-modified low-density lipoprotein cholesterol and vascular inflammation evaluated by 18F-FDG PET/CT.
    Kaida H; Tahara N; Tahara A; Honda A; Nitta Y; Igata S; Ishibashi M; Yamagishi S; Fukumoto Y
    Atherosclerosis; 2014 Dec; 237(2):404-9. PubMed ID: 25463065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-density lipoprotein apheresis for the treatment of refractory hyperlipidemia.
    Vella A; Pineda AA; O'Brien T
    Mayo Clin Proc; 2001 Oct; 76(10):1039-46. PubMed ID: 11605688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apheresis technologies for prevention and regression of atherosclerosis: clinical results.
    Bambauer R; Schneidewind JM; Latza R
    ASAIO J; 1999; 45(5):403-7. PubMed ID: 10503615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary atherosclerosis reduced in patients with familial hypercholesterolemia after intensive cholesterol lowering with low-density lipoprotein-apheresis: 1-year follow-up study. The Osaka LDL-Apheresis Multicenter Trial Group.
    Kitabatake A; Sato H; Hori M; Kamada T; Kubori S; Hoki N; Minamino T; Yamada M; Kato T
    Clin Ther; 1994; 16(3):416-28. PubMed ID: 7923308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein apheresis and acute reduction of arterial inflammation: FDG-PET as an imaging biomarker of nonpharmacological effects on the vessel wall.
    Tsimikas S
    J Am Coll Cardiol; 2014 Oct; 64(14):1427-9. PubMed ID: 25277611
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of different low density lipoprotein apheresis machines on brain natriuretic Peptide levels in patients with familial hypercholesterolemia.
    Moriarty P; Sosland R; Gibson C; Belmont J
    Ther Apher Dial; 2010 Feb; 14(1):74-8. PubMed ID: 20438521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular events in patients with familial hypercholesterolemia and hyperlipoproteinaemia (a): Indications for lipoprotein apheresis in Poland.
    Mickiewicz A; Marlega J; Kuchta A; Bachorski W; Cwiklinska A; Raczak G; Gruchala M; Fijalkowski M
    J Clin Apher; 2021 Jun; 36(3):370-378. PubMed ID: 33386762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apheresis-inducible cytokine pattern change in children with homozygous familial hypercholesterolemia.
    Küçükçongar A; Yenicesu I; Tümer L; Kasapkara CS; Ezgü FS; Paşaoğlu O; Demirtaş C; Celik B; Dilsiz G; Hasanoğlu A
    Transfus Apher Sci; 2013 Jun; 48(3):391-6. PubMed ID: 23651865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein apheresis and new therapies for severe familial hypercholesterolemia in adults and children.
    Page MM; Bell DA; Hooper AJ; Watts GF; Burnett JR
    Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):387-403. PubMed ID: 24840266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.